ERBB2 and neoplasm: The pCR and non-pCR groups differed significantly in age (p=0.020), HER2 status (p<0.001), and post-NAC tumor size (LAM, p=0.030; DAM, p=0.008; MSM, p=0.031; DLM, p=0.009).